Researchers at Tampere University have developed a 3D printed ceramic implant that closely replicates the composition and internal architecture of natural human bone. Published in Materials Today Bio, the work advances the case for patient-specific bone regeneration without the need for donor tissue, synthetic drugs, or growth factors, and may offer a more accessible path to treating bone defects as the global population ages.
A Procedure Performed Two Million Times a Year, Still Relying on Donor Bone
Bone grafting is the second most common tissue transplantation procedure performed worldwide, yet the dominant approaches, harvesting bone from the patient or sourcing it from a donor, remain constrained by supply, surgical complexity, and recovery burden. As populations age and the incidence of bone defects from trauma, disease, and degeneration rises, the limitations of these methods are becoming harder to work around.
Synthetic alternatives have existed for decades, but most have struggled to replicate what makes bone biologically functional: not just its mineral content, but the precise internal geometry that allows cells to colonize, interact, and form new tissue. That geometry has proven difficult to engineer at the level of precision the body requires.
Printing With the Same Material Nature Uses
The Tampere team, led by Antonia Ressler, Postdoctoral Research Fellow at the Tampere Institute for Advanced Study, chose hydroxyapatite as their base material, the same calcium phosphate compound that forms the mineral structure of real bone. Using ceramic vat photopolymerization, a 3D printing method that cures ceramic resin layer by layer with light, the researchers were able to precisely control the internal architecture of the resulting scaffolds.
After four years of work under the EU-funded AffordBoneS project, the team identified an optimal scaffold geometry: internal pores of approximately 400 micrometers and roughly 45% overall porosity. In testing, this configuration struck the balance needed for bone-forming cells to enter, establish contact with one another, and begin generating new tissue.
“This architecture achieved a crucial balance between strength and biological performance, allowing bone-forming cells to enter the material, interact with one another, and successfully begin forming new bone tissue,” said Ressler.
The team also identified a less obvious variable: surface chemistry. High sintering temperatures required during processing altered the surface in ways that impaired cell attachment, a finding that underscores how much more is at play in implant performance than material composition alone.
“We found that the high temperatures required during processing can alter the surface of the material in ways that make it more difficult for human cells to attach. Our finding highlights that not only the composition, but also the surface properties of biomaterials are critical for successful bone regeneration,” she said.
Because the implants are digitally designed from patient imaging data, they can be shaped to match specific defect geometries, eliminating the compromises of off-the-shelf solutions. The researchers estimate this type of implant could enter routine clinical use within a decade.
Developing Synthetic Bone That Actually Works
The challenge the Tampere team is tackling sits at the center of one of regenerative medicine’s most active engineering problems: how to manufacture a synthetic scaffold that is not just structurally adequate, but biologically compelling enough for the body to build real bone through it.
Several parallel efforts have moved this question from the lab toward the clinic. Chicago-based Dimension Inx developed CMFlex, a 3D printed regenerative bone graft built from hydroxyapatite and biodegradable polymers, structured with macro, micro, and nano-level features to promote bone regeneration, and became the first such product to receive FDA 510(k) clearance for oral and maxillofacial surgical applications.
On the academic side, researchers at the University of New South Wales developed a ceramic omnidirectional bioprinting technique that deposits calcium phosphate ink directly into damaged tissue at room temperature, hardening within minutes, enabling in-situ bone repair and opening possibilities for treating defects caused by trauma or cancer.
Further along the biodegradable path, researchers at UNSW Canberra developed a 3D printed biodegradable bone scaffold that closely mimics the internal structure of natural bone, designed to dissolve naturally after healing and eliminate the need for a second surgery to remove the implant.
What the Tampere work adds is a systematic evaluation of how porosity, sintering temperature, mineralogical phase, and trace element composition interact to determine whether human cells will actually colonize a scaffold and begin forming bone.
3D Printing Industry is inviting speakers for its 2026 Additive Manufacturing Applications (AMA) series, covering Energy, Healthcare, Automotive and Mobility, Aerospace, Space and Defense, and Software. Each online event focuses on real production deployments, qualification, and supply chain integration. Practitioners interested in contributing can complete the call for speakers form here.
To stay up to date with the latest 3D printing news, don’t forget to subscribe to the 3D Printing Industry newsletter or follow us on LinkedIn.
Explore the full Future of 3D Printing and Executive Survey series from 3D Printing Industry, featuring perspectives from CEOs, engineers, and industry leaders on the industrialization of additive manufacturing, 3D printing industry trends 2026, qualification, supply chains, and additive manufacturing industry analysis.
Featured image shows 3D printed scaffolds that mimic the chemical composition and architecture of natural bone tissue. Photo via Jonne Renvall and Tampere Institute.
